Barrett Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Barrett Asset Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-4,900	Closed	-$62K	–	412
2017 Q3	$62K	Hold	4,900	–	–	﹤0.01%	220
2017 Q2	$58K	Hold	4,900	–	–	﹤0.01%	234
2017 Q1	$72K	Hold	4,900	–	–	0.01%	203
2016 Q4	$79K	Hold	4,900	–	–	0.01%	196
2016 Q3	$89K	Hold	4,900	–	–	0.01%	184
2016 Q2	$81K	Hold	4,900	–	–	0.01%	189
2016 Q1	$81K	Buy	4,900 +800	+20%	+$14K	0.01%	181
2015 Q4	$89K	Buy	4,100 +3,850	+1,540%	+$74.9K	0.01%	173
2015 Q3	$5K	Buy	+250	New	+$7.9K	﹤0.01%	296

Other funds holding HZNP

Scopia Capital Management New York $144M AUM 25.93% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

William Blair Investment Management

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return